ClinicalTrials.Veeva

Menu

A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Unknown

Conditions

Pancreatic Cancer

Treatments

Other: Observation

Study type

Observational

Funder types

Other

Identifiers

NCT05138302
CPOG2021015

Details and patient eligibility

About

This study aims to know the status of BRCA and DDR genes in PDAC patients in China. Peripheral venous blood samples of the patients will be collected for next-generation sequencing of BRCA and DNA damage repair related genes. At the same time, it is necessary to record clinical information such as age, gender, tumor pathological type, tumor stage and grade, whether surgery is performed, the size of postoperative residual lesions, and treatment methods. Prognostic indicators include the association of factors such as PFS, ORR, and DCR are also recorded.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with pancreatic cancer
  • PS score ≤ 2
  • no severe heart, cerebrovascular disease, severe coagulation dysfunction or severe mental disorder

Exclusion criteria

  • PS score > 2
  • with severe heart, cerebrovascular disease, severe coagulation dysfunction or severe mental disorder

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems